A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Clinical trial NCT01876251 · TERMINATED

Trial details

NCT number: NCT01876251
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2013-11-04
Primary completion: 2015-12-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.